OCM
VRTX icon

One Capital Management’s Vertex Pharmaceuticals VRTX Stock Holding History

One Capital Management’s Portfolio VRTX Stock Details VRTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$297K Buy
664
+23
+4% +$10.7K 0.01% 461
2025
Q4 		$291K Sell
641
-15
-2% -$6.46K 0.01% 453
2025
Q3 		$257K Sell
656
-110
-14% -$46K 0.01% 440
2025
Q2 		$341K Buy
766
+204
+36% +$94K 0.01% 393
2025
Q1 		$272K Buy
+562
New +$262K 0.01% 354

Other funds holding VRTX

Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

One Capital Management's VRTX Position: Q1 2026 in Review

One Capital Management increased its Vertex Pharmaceuticals (VRTX) stake by 3.6% in Q1 2026, buying an estimated $10.7K and bringing the position to 664 shares worth $297K. The position accounts for 0.01% of the portfolio, ranked #461.

One Capital Management first reported a position in VRTX in Q1 2025 and has held it in 5 quarters since. The position peaked at $341K in Q2 2025. 1,687 funds tracked by Wall St. Rank hold VRTX as of Q1 2026.

  • One Capital Management held 664 shares of Vertex Pharmaceuticals worth $297K as of Q1 2026.
  • One Capital Management bought 23 Vertex Pharmaceuticals shares in Q1 2026, an estimated $10.7K.
  • Vertex Pharmaceuticals made up 0.01% of One Capital Management's portfolio in Q1 2026, its #461 holding.
  • One Capital Management first reported a position in Vertex Pharmaceuticals in Q1 2025 and has held it in 5 quarters since.
  • One Capital Management's Vertex Pharmaceuticals position peaked at $341K in Q2 2025.
  • 1,687 funds tracked by Wall St. Rank held Vertex Pharmaceuticals as of Q1 2026.

Based on One Capital Management's 13F filing for Q1 2026, filed 13 May 2026.